Literature DB >> 22826141

Fibrillary glomerulonephritis complicated by membranous nephropathy in a patient with tuberculosis.

Xueguang Liu1, Hong Liu, Zhonghua Zhao, Zhigang Zhang, Xiaoqiang Ding.   

Abstract

Fibrillary glomerulonephritis (FGN) is a morphologically defined entity characterized by glomerular accumulations of non-branching, randomly arranged fibrils; these differ from amyloid fibrils by their larger size and lack of reactivity with Congo red and other amyloid-specific dyes. FGN is a rare disease and may mimic membranous nephropathy under routine light microscopy and immunohistochemistry. However, electron microscopy shows the fibrillary nature of these glomerular deposits. We report a rare case of membranous nephropathy complicated by fibrillary deposits in a 60-year-old man with a history of bone tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22826141     DOI: 10.1007/s11255-012-0236-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  Fibrillary glomerulonephritis and immunotactoid glomerulopathy.

Authors:  Bela Ivanyi; Peter Degrell
Journal:  Nephrol Dial Transplant       Date:  2004-09       Impact factor: 5.992

2.  Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association.

Authors:  Zeenat Y Bhat; Xu Zeng; Jaideep Hingorani; Salman Khan; Madhumita Jena Mohanty
Journal:  Int Urol Nephrol       Date:  2011-11-19       Impact factor: 2.370

3.  Nephrotic syndrome associated with amyloid-like glomerular deposits.

Authors:  E Rosenmann; M Eliakim
Journal:  Nephron       Date:  1977       Impact factor: 2.847

4.  Lumbar tuberculosis associated with membranous nephropathy and interstitial nephritis.

Authors:  Quan Yuan; Li Sun; Jiangmin Feng; Nan Liu; Yi Jiang; Jianfei Ma; Lining Wang
Journal:  J Clin Microbiol       Date:  2010-04-07       Impact factor: 5.948

5.  Fibrillary glomerulonephritis mimicking membranous nephropathy--a diagnostic pitfall.

Authors:  J Müller-Höcker; M Weiss; Th Sitter; W Samtleben
Journal:  Pathol Res Pract       Date:  2009-01-15       Impact factor: 3.250

6.  Rituximab treatment of fibrillary glomerulonephritis.

Authors:  Michael Collins; Sankar D Navaneethan; Miriam Chung; James Sloand; Bruce Goldman; Gerald Appel; Brad H Rovin
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

7.  Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.

Authors:  Sandhya Sundaram; Roshan Mainali; Evan R Norfolk; John H Shaw; Ping L Zhang
Journal:  Ann Clin Lab Sci       Date:  2007       Impact factor: 1.256

8.  Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

Authors:  Jordan L Rosenstock; Glen S Markowitz; Anthony M Valeri; Giuseppe Sacchi; Gerald B Appel; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

9.  Fibrillary glomerulonephritis and immunotactoid glomerulopathy.

Authors:  Charles E Alpers; Jolanta Kowalewska
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

  9 in total
  3 in total

1.  Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.

Authors:  Shaoshan Liang; Dacheng Chen; Dandan Liang; Feng Xu; Mingchao Zhang; Fan Yang; Xiaodong Zhu; Ping Li; Caihong Zeng
Journal:  J Nephrol       Date:  2020-06-18       Impact factor: 3.902

2.  Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy.

Authors:  Wenling Ye; Yingyi Wang; Yubing Wen; Hang Li; Xuemei Li
Journal:  Int Urol Nephrol       Date:  2014-01-11       Impact factor: 2.370

Review 3.  Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).

Authors:  Nattawat Klomjit; Mariam Priya Alexander; Ladan Zand
Journal:  Kidney360       Date:  2020-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.